- Home
- CATX vs SABA Comparison
CATX vs SABA Comparison
Compare CATX & SABA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CATX
- SABA
- Stock Information
- Founded
- CATX 1983
- SABA 1988
- Country
- CATX United States
- SABA United States
- Employees
- CATX N/A
- SABA N/A
- Industry
- CATX Medical/Dental Instruments
- SABA
- Sector
- CATX Health Care
- SABA
- Exchange
- CATX Nasdaq
- SABA Nasdaq
- Market Cap
- CATX 239.0M
- SABA 258.2M
- IPO Year
- CATX N/A
- SABA N/A
- Fundamental
- Price
- CATX $3.88
- SABA $9.32
- Analyst Decision
- CATX Strong Buy
- SABA
- Analyst Count
- CATX 11
- SABA 0
- Target Price
- CATX $12.90
- SABA N/A
- AVG Volume (30 Days)
- CATX 934.1K
- SABA 290.0K
- Earning Date
- CATX 08-13-2025
- SABA 01-01-0001
- Dividend Yield
- CATX N/A
- SABA 12.91%
- EPS Growth
- CATX N/A
- SABA N/A
- EPS
- CATX N/A
- SABA N/A
- Revenue
- CATX $1,471,000.00
- SABA N/A
- Revenue This Year
- CATX N/A
- SABA N/A
- Revenue Next Year
- CATX N/A
- SABA N/A
- P/E Ratio
- CATX N/A
- SABA N/A
- Revenue Growth
- CATX N/A
- SABA N/A
- 52 Week Low
- CATX $1.60
- SABA $3.64
- 52 Week High
- CATX $16.55
- SABA $4.42
- Technical
- Relative Strength Index (RSI)
- CATX 50.75
- SABA 59.31
- Support Level
- CATX $3.88
- SABA $9.13
- Resistance Level
- CATX $4.28
- SABA $9.37
- Average True Range (ATR)
- CATX 0.29
- SABA 0.12
- MACD
- CATX -0.06
- SABA -0.00
- Stochastic Oscillator
- CATX 14.61
- SABA 83.87
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
About SABA Saba Capital Income & Opportunities Fund II Shares of Beneficial Interest
Saba Capital Income & Opportunities Fund II is a closed-end fund. The company seeks high current income, with a secondary goal of capital appreciation. The fund invests in fixed income markets across the globe.